The National Academy of Medicine hosted science, technology, and policy professionals from the Washington, D.C., region for breakfast and conversation as we explored emerging neurotechnologies with a focus on how advances in neural sensing, modulation, and adaptive brain–computer systems are reshaping possibilities for treating neurological and psychiatric conditions.
As tools for decoding, stimulating, and potentially optimizing brain function move from research settings toward clinical and commercial deployment, they raise complex questions around safety, personal agency, data governance, equity, regulatory oversight, and responsible integration into health systems. The event fostered cross-sector dialogue on how innovation in neurotechnology can proceed in ways that are scientifically rigorous, ethically grounded, and socially responsive.
Agenda:
- Breakfast & Networking
- Welcome and Introductions by Cara LaPointe,جGeorgetown University Center for Security and Emerging Technology
- ±ت°ù±ً²ُ±ً²ش³ظ²¹³ظ¾±´ا²شج²ْ²âجJohn Ngai,جNational Institutes of Health Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
- Reflection on Implications for Responsible Innovation and Governanceآ ²ْ²âجAnna Wexler,جUniversity of Pennsylvania Division of Medical Ethics and Health Policy
- ¶ظ¾±²ُ³¦³ـ²ُ²ُ¾±´ا²شجmoderated byآ Debra Mathews,جJohns Hopkins Berman Institute of Bioethics
Bagels and Biotech is an initiative of the ذكذكتسٍ¤ Action Collaborative on Translating Emerging Science, Technology, and Innovation in collaboration with the National Academies Programs on Biomedical and Health Sciences & Life Sciences and Biotechnology.
